Avantor, Inc. (AVTR)

Market Cap	5.67B -46.3%
Revenue (ttm)	6.55B -2.0%
Net Income	-551.40M
EPS	-0.81
Shares Out	682.76M
PE Ratio	n/a
Forward PE	10.17
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,978,176
Open	8.32
Previous Close	8.31
Day's Range	8.10 - 8.40
52-Week Range	7.27 - 15.93
Beta	0.93
Analysts	Hold
Price Target	12.23 (+47.17%)
Earnings Date	Apr 29, 2026

About AVTR

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education an...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 17, 2019
• Employees: 13,500
• Stock Exchange: NYSE
• Ticker Symbol: AVTR
• Website: https://www.avantorsciences.com

Analyst Summary

According to 13 analysts, the average rating for AVTR stock is "Hold." The 12-month stock price target is $12.23, which is an increase of 47.17% from the latest price.

Price Target

$12.23

(47.17% upside)

Analyst Consensus: Hold